Product Images Gemcitabine

The text seems to be a statistical report comparing the progression-free probability between two different medications, Gemcitabine/Paclitaxel and Paclitaxel. The report provides the respective progression-free probabilities, measured in months, for both medications and indicates the number of participants for each medication. Additionally, the report states that the Log rank p-value is less than 0.0001. The rest of the text consists of errors and is not readable.*

Gemcitabine is a lyophilized powder contained in a vial. It contains gemcitabine HC equivalent to 2 gemcitabine, as well as inactive ingredients such as manitol and sodium acetate. The powder should be reconstituted with 50 mL of 0.9% sodium chloride injection to create a solution containing 38 mg/mL. The solution should be shaken, administered within 24 hours, and any unused portion should be discarded. It is important to follow the package insert for use and storage directions, as gemcitabine hydrochloride is a potential cytotoxic agent. The product is for intravenous use only and must be diluted. The container closure is not made with natural rubber latex.*